Log in or Sign up for Free to view tailored content for your specialty!
Pain Management News
Natural grass may lead to more severe football concussions than artificial turf
In young male American football players, concussion symptoms and severity were higher for those who sustained the injury on natural grass compared with artificial turf, according to new research in the Clinical Journal of Sports Medicine.
FDA grants RMAT designation to myasthenia gravis therapeutic
The FDA has granted Regenerative Medicine Advanced Therapy designation to an autologous, fully human CD19 chimeric antigen receptor T-cell therapy candidate, to treat those with progressive myasthenia gravis.
Log in or Sign up for Free to view tailored content for your specialty!
FDA approves Asleep Deep Brain Stimulation surgery for Parkinson’s, essential tremor
The FDA has approved Medtronic’s Asleep Deep Brain Stimulation surgery for individuals diagnosed with Parkinson’s disease as well as those with essential tremor, according to the manufacturer.
Q&A: ‘Groundbreaking’ intranasal brain cancer treatment bypasses blood-brain barrier
Bypassing the blood-brain barrier remains an obstacle for novel therapeutics. Healio spoke to Thomas Chen, MD, PhD, founder and CEO of NeOnc, to find out how a novel nasal spray formulation to treat brain cancer overcomes these challenges.
FDA grants fast track designation to cyclobenzaprine tablets for fibromyalgia
The FDA has granted fast track designation to a sublingual tablet form of the muscle relaxant cyclobenzaprine hydrochloride for the management of fibromyalgia, according to a press release from the manufacturer.
Ajovy superior to placebo at 12 weeks for episodic migraine in young people
Ajovy offers “significant efficacy” compared with placebo to address episodic migraine in children and adolescents, according to topline results from the phase 3 SPACE study.
NYU Langone tops list again as best US hospital for neurology, neurosurgery
NYU Langone was again the top hospital in the United States for neurology and neurosurgery, according to the latest annual Best Hospitals Survey issued by U.S. News & World Report.
Initial testing promising for hemostatic hydrogel to treat TBI
A Brooklyn-based biotech firm has announced successful completion of the first phase of a preclinical study conducted with the Walter Reed Army Institute of Research involving a proprietary hemostatic hydrogel to treat traumatic brain injury.
Vistagen announces new patents for investigational pherine nasal spray to treat migraine
A clinical-stage neuroscience-focused biopharmaceutical company has received new international patents related to an investigational neuroactive pherine nasal spray to potentially treat individuals with migraine.
No significant difference in clinical outcomes, recovery in college athletes with concussion
No significant differences were found in clinical outcomes or recovery time in college athletes who returned to play following concussion compared with those immediately removed, according to research from Neurosurgical Focus.
-
Headline News
'We're listening': ABIM axes 'confusing' MOC program requirement
December 04, 20244 min read -
Headline News
Zepbound bests Wegovy in head-to-head weight-loss trial
December 04, 20241 min read -
Headline News
Children who attend day care less likely to develop type 1 diabetes
December 03, 20242 min read
-
Headline News
'We're listening': ABIM axes 'confusing' MOC program requirement
December 04, 20244 min read -
Headline News
Zepbound bests Wegovy in head-to-head weight-loss trial
December 04, 20241 min read -
Headline News
Children who attend day care less likely to develop type 1 diabetes
December 03, 20242 min read